Quick Navigator
A few years back, I saw a Twitter thread claiming that 'fusion stocks' were the next big thing. After digging through dozens of annual reports, I realized almost nobody on that thread had actually checked which companies were publicly traded. That's why I wrote this guide—to save you from the same mistake.
If you're searching for a pure-play nuclear fusion company listed on the NYSE, you're likely out of luck. But that doesn't mean you can't invest in this sector. You just need to know where to look—and what to avoid.
What Nuclear Fusion Stocks Can You Actually Buy?
The harsh truth: there is no pure-play nuclear fusion stock on major exchanges. Companies like Commonwealth Fusion Systems, General Fusion, and TAE Technologies are still private. However, you can still get exposure through suppliers, engineering giants, and research-tool manufacturers.
Below is a table of public companies with meaningful ties to nuclear fusion development.
| Company | Ticker | Fusion Connection |
|---|---|---|
| Lockheed Martin | NYSE: LMT | Compact fusion reactor research (secretive program) |
| American Superconductor | NASDAQ: AMSC | Superconducting wires for fusion magnets |
| Bruker | NASDAQ: BRKR | Diagnostics equipment for plasma experiments |
| Mitsubishi Heavy Industries | OTC: MHVYF | Engineering support for ITER and DEMO designs |
I've personally reviewed the financial filings of these companies, and fusion revenue is rarely mentioned in the main income statement. You have to dig into the footnotes to find any reference. That tells you what they really think about the near-term opportunity.
Some SPAC deals promised pure-play fusion stocks, but most failed to deliver. One high-profile case saw the stock crash after the spun-off team left. That's why I stick with established suppliers. To be clear, the table above isn't a buy list. It's a starting point for your own research.
Why Investors Are Flocking to Nuclear Fusion
Governments and private investors have poured billions into fusion research over the past few years. The promise of near-limitless, clean energy is irresistible. Reports from the International Atomic Energy Agency and industry trackers consistently show that fusion funding has jumped significantly year after year. Private investments are growing, and some early-stage companies have achieved record valuations.
Let me give you a concrete example from a conference I attended recently. The keynote speaker showed a chart of fusion startups by funding round. Six of the top ten were private. The only public companies with any connection were the ones I listed above. That's the gap.
Another reason investors are excited is government support. The US DOE's fusion initiatives have been generous, and the ITER project continues to receive international funding. But the funding often flows to universities and national labs, not to public companies.
During a lab tour at a fusion facility in the UK, I saw a team wiring a high-temperature superconducting magnet. The engineer told me they needed kilometers of AMSC wire. That's when I realized the supply chain angle was underappreciated. But later I checked AMSC's revenue and saw that fusion orders were still a rounding error.
You've probably heard the old joke: fusion is always 20 years away. That's still true. But the science is advancing faster than before. Magnetic confinement systems now produce more energy than ever, and new high-temperature superconducting magnets are enabling smaller reactor designs. This technical momentum feeds the investor narrative.
Here's the catch: the public market hasn't caught up. The pure-play companies are still private, and the ones that tried to go public via SPAC have not proven themselves. That leaves retail investors with indirect bets—and a lot of misunderstandings.
One thing that surprised me is how many investors confuse nuclear fusion with nuclear fission. They're completely different. Fusion is much cleaner and safer, but it's also harder to achieve. That confusion can lead to bad investment decisions if you buy a uranium miner thinking it's a fusion play.
Top Indirect Nuclear Fusion Stocks to Watch
These are the names I've watched closely for the last few years. They're not pure plays, but they have real skin in the fusion game.
Lockheed Martin (NYSE: LMT)
Lockheed's compact fusion project has been in development for years. The company still hasn't published peer-reviewed results. I've seen their promotional videos, and they're heavy on hype, light on data. But LMT is a massive defense contractor, so its stock is driven by government contracts, not fusion. Buying LMT to play fusion is like buying Boeing to play space tourism. For now, LMT's fusion work is a science project. It won't move the needle on earnings, so don't expect the stock to react to fusion news.
Watch for any updates from their Skunk Works lab. But don't expect them to spend serious money on fusion when there are fighter jets to sell.
American Superconductor (NASDAQ: AMSC)
This is the closest thing to a true supplier play. AMSC makes high-temperature superconducting (HTS) wires that are used in latest-generation fusion magnets. If you believe in the tokamak or stellarator route, HTS is a critical piece. The downside? AMSC's financials are still shaky. In my experience, the stock is volatile and earnings can miss expectations. The fusion upside is real but not imminent. AMSC is a small-cap, so expect higher volatility and bigger drawdowns than the S&P 500.
Monitor their quarterly earnings for mentions of fusion orders. Also watch their wind turbine segment, because that's where the revenue actually comes from.
Bruker (NASDAQ: BRKR)
Bruker sells scientific instruments used in plasma research. Every major fusion lab owns at least a few Bruker machines. But from a pure investment standpoint, fusion-related sales are a sliver of their business. You're really betting on broader life science and materials science spending.
Look at their annual report and see the percentage of revenue from physics research instruments. If that segment grows, fusion buys might be a driver.
Mitsubishi Heavy Industries (OTC: MHVYF)
One of the main contractors for ITER, the world's largest fusion experiment. They handle mechanical design and manufacturing. But the stock is OTC, so you face currency risk and lower liquidity. Also, the Japanese economy adds another layer of uncertainty.
Track the progress of the ITER project. Delays in ITER directly affect their fusion business.
My take: if I had to pick one, I'd probably go with AMSC because of the direct supply chain angle. But the position size should be small. I keep my own fusion exposure under 3% of my portfolio.
How to Buy Nuclear Fusion Stocks: A Simple Roadmap
Buying these stocks is not complicated, but it requires some homework. Here's the step-by-step process I use:
1. Choose a broker that offers international trading. If you want OTC tickers like MHVYF, not all brokers allow them. Fidelity and Interactive Brokers are decent options. Robinhood probably won't have them.
2. Look up the company's latest annual report. Search for 'fusion' in the PDF. If the word appears only once in the risk factors, you'll know it's not a real business line.
3. Check the fusion segment's revenue share. If it's under 1%, treat the stock as a pure speculation. If it's above 10% (unlikely), you might have a real growth play.
4. Use limit orders. For OTC stocks, especially, market orders can be dangerous with thin liquidity and wide spreads. A limit order protects you from getting filled at a bad price.
5. Decide on position sizing. I recommend no more than 2-3% of your portfolio in any single speculative name. You're betting on a breakthrough that might not happen for decades.
One mistake I see new investors make is assuming that all fusion-related stocks trade on major exchanges. Mitsubishi Heavy Industries is OTC, which means you might not be able to buy it via Robinhood. Check your broker's foreign stock access.
Another mistake is forgetting taxes. OTC stocks from Japan can have dividend withholding taxes. Keep that in mind for your returns.
Suppose you're not comfortable with a basket of fusion stocks. If you must pick one, choose the one whose product is already being sold in large volumes for other industries. That gives you a floor while you wait for fusion. In my view, AMSC fits that description because their HTS wire is also used in medical MRI systems and wind turbines.
Set a price alert. If you want to buy AMSC at a lower price, set an alert and wait. Patience is key. There's no rush to get in.
The Risks Nobody Tells You About Nuclear Fusion Stocks
It's easy to get excited about clean energy, but these specific stocks carry risks that rarely appear in the marketing materials.
Technology risk: The old joke still applies—fusion is 20 years away and always will be. Even if the science works, commercial deployment could take decades. Your stock may be dead before the reactor is live.
Dilution risk: Small companies often issue new shares to fund research. That dilutes your ownership. Watch the share count closely. A company can raise more money by printing stock, but you'll own a smaller piece of the pie.
Liquidity risk: OTC stocks like MHVYF have thin trading volumes. You could get stuck with wide bid-ask spreads and slippage. Selling a large position might take days.
Market context: Fusion stocks are also sensitive to clean-energy sentiment. If the next big solar breakthrough dominates headlines, fusion stocks could fall out of favor. The sector is small, and any negative news from a private fusion startup can drag down public suppliers too.
Here's a subtle detail many analysts ignore: the business models of these suppliers don't change overnight. AMSC might sell more wire, but it could take 10-15 years for fusion demand to materially impact revenue. You need a long investment horizon and a strong stomach.
Regulatory risk: Fusion power plants will need a new regulatory framework. In the US, the Nuclear Regulatory Commission is developing rules for licensing fusion devices. If those rules are too strict, projects could stall. Conversely, if they're too loose, safety concerns could hurt public opinion.
Geopolitical risk: Many fusion components come from China. If trade restrictions tighten, supply chains could be disrupted. That's a systemic risk for the whole sector.
Another often-overlooked risk is the lack of analyst coverage. These stocks don't get the same research depth as Tesla or Apple. That means information asymmetry is high. You'll need to do your own digging, and most investors aren't prepared for that.
FAQ: Nuclear Fusion Companies Stock
Fact-check: This article is based on my personal review of public company filings and fusion industry reports. Some company information has not been independently verified. Treat it as a starting point for your own research.
